Vutrisiran reduces mortality in transthyretin amyloidosis with cardiomyopathy
1. Vutrisiran treatment reduced the risk of death and recurrent cardiovascular events compared to placebo in patients with transthyretin amyloidosis ...
Tag: Amyloidosis
Daratumumab therapy addition improved response in systemic immunoglobulin light-chain amyloidosis
1. Daratumumab therapy addition to bortezomib, cyclophosphamide, and dexamethasone showed improved cancer response in patients with systemic immunoglobulin light-chain amyloidosis. ...
Patisiran therapy reduces ventricular myocardial strain in hereditary transthyretin amyloidosis
1. Use of patisiran, an RNA interference therapy, in patients with hereditary transthyretin (hATTR) cardiac amyloidosis was linked to reduced ...
Patient Basics: Amyloidosis
Originally published by Harvard Health. What Is It? Amyloidosis is a disease in which an abnormal protein called amyloid accumulates ...